Surrozen (SRZN)

• Market cap: $117M
• 1 day: -1.09%
• 5 days: -2.3%
• 1 month: 17.65%
• 3 months: 61.9%
• 6 months: 41.67%
• Year to date: -4.56%
• 1 year: 29.52%
• 5 years: -91.03%
• 10 years: -91.03%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41